Dapsone 8.5% / Niacinamide 2% / Spironolactone 5%
Product Images NDC 72934-1064

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone 8.5% / Niacinamide 2% / Spironolactone 5% (NDC 72934-1064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

De (2 End)

FDA Label Image

A (1064 2 Front)

FDA Label Image

Dw (1064 2 Middle)

Dw (1064 2 Middle)
This is a medication with active ingredients such as Bapsone USP, Niacinamide USP, and Spironolactone USP mainly used for treating severe acne. It also has inactive ingredients such as Lavender oil, Polyethylene glycol USP, and, Suspenissee Gl.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.